Journal List > Ann Clin Microbiol > v.19(3) > 1078557

Song, Yoo, Hwang, and Uh: Evaluation of Diagnostic Performance of RAPIDEC CARBA NP Test for Carbapenemase-Producing Enterobacteriaceae

Abstract

Background

Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are resistant to most β-lactam antibiotics except carbapenems. In recent years, infrequently isolated Enterobacteriaceae that produce carbapenemase pose a serious threat in the selection of appropriate therapeutic antibiotics. The rapid detection method of carbapenemase-producing Enterobacteriaceae (CPE) is necessary to prevent the spread of CPE into healthcare facilities.

Methods

One hundred clinical Enterobacteriaceae isolates (Klebsiella pneumoniae 40, Escherichia coli 40, others 20) showing susceptibility to carbapenems and positivity in the CLSI ESBL phenotypic test from November 2015 to March 2016 and 59 stocked Enterobacteriaceae isolates harboring resistance genes producing carbapenemase (K. pneumoniae 56, Enterobacter cloacae 2, E. coli 1; types of CPE: KPC 36, GES 12, NDM 6, VIM 2, OXA 2, IMP 1) were sub-jected to the RAPIDEC CARBA NP test (bioMérieux, France) and CPE phenotypic test using the modified Hodge test (MHT) and carbapenemase inhibition test.

Results

All of the 100 Enterobacteriaceae isolates with carbapenem susceptibility and ESBL positivity were negative on the RAPIDEC CARBA NP test and CPE phenotypic test. Of 59 stock CPE isolates, 53 and 42 showed positive results to the RAPIDEC CARBA NP test and MHT, respectively. The sensitivity and specificity of the RAPIDEC CARBA NP test for detecting CPE were 89.8% and 100%, respectively.

Conclusion

The RAPIDEC CARBA NP test is simple and produces a result within 3 hr. In conclusion, the test is a useful screen for detecting CPE because it shows high sensitivity and specificity for CPE detection.

References

1. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008; 29:996–1011.
2. Jacoby GA and Munoz-Price LS. The new β-lactamases. N Engl J Med. 2005; 352:380–91.
crossref
3. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011; 53:60–7.
crossref
4. Garg A, Garg J, Upadhyay GC, Agarwal A, Bhattacharjee A. Evaluation of the rapidec carba NP test kit for detection of carbapenemase-producing gram-negative bacteria. Antimicrob Agents Chemother. 2015; 59:7870–2.
crossref
5. Poirel L and Nordmann P. Rapidec Carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol. 2015; 53:3003–8.
6. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012; 18:1503–7.
7. CLSI. Performance standards for antimicrobial susceptibility testing. CLSI document M100S. Wayne, PA: Clinical and Laboratory Standards Institute;2016.
8. Jeong S, Kim JO, Jeong SH, Bae IK, Song W. Evaluation of peptide nucleic acid-mediated multiplex realtime PCR kits for rapid detection of carbapenemase genes in gram-negative clinical isolates. J Microbiol Methods. 2015; 113:4–9.
crossref
9. Song W, Hong SG, Yong D, Jeong SH, Kim HS, Kim HS, et al. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp. Ann Lab Med. 2015; 35:212–9.
crossref
10. Thomson KS. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol. 2010; 48:1019–25.
crossref
11. Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol. 2012; 50:477–9.
crossref
12. Dortet L, Agathine A, Naas T, Cuzon G, Poirel L, Nordmann P. Evaluation of the RAPIDEC CARBA NP, the Rapid CARB Screen and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2015; 70:3014–22.
13. Kabir MH, Meunier D, Hopkins KL, Giske CG, Woodford N. A two-centre evaluation of RAPIDEC CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. J Antimicrob Chemother. 2016; 71:1213–6.
14. Studentova V, Papagiannitsis CC, Izdebski R, Pfeifer Y, Chudackova E, Bergerova T, et al. Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers. Folia Microbiol (Praha). 2015; 60:119–29.
crossref
15. Park JW, Lee EJ, Lee DH. Status of carbapenemase-producing Enterobacteriaceae in Korea, 2014. Public Health Weekly Report. 2016; 9:9–13.

Fig. 1.
Phenotype results of KPC-producing K. pneumoniae. (A) Positive finding in RAPIDEC CARBA NP,(B) Positive finding in MHT and CIT. Abbreviations: P, phenylboronic acid disk; M, meropenem disk; E, EDTA disk.
acm-19-59f1.tif
Table 1.
Results of RAPIDEC CARBA NP test result according to reading time
Results by reading time
Type of CPE (No. of tested isolates) 30 min 120 min Final  
  Negative Positive Negative Positive Negative Equivocal Positive
Non-CPE (100) 100 0 100 0 100 0 0
CPE (59)              
KPC-2 (15) 0 15 0 15 0 0 15
KPC-3 (21) 0 21 0 21 0 0 21
GES-5 (12) 7 5 (2) 5 7 (2) 5 2* 7
NDM-1 (6) 0 6 0 6 0 0 6
VIM-2 (2) 0 2 0 2 0 0 2
OXA-48 (1) 0 1 0 1 0 0 1
OXA-181 (1) 0 1 (1) 0 1 0 0 1
IMP-1 (1) 1 0 1 0 1 0 1
Total 8 51 6 53 6 2 53

No. in parenthesis means that isolate show weakly positive result.*One isolate changed from weakly positive (30 min) to negative (120 min), one isolate changed from negative to weakly positive. Abbreviation: CPE, carbapenemase-producing Enterobacteriaceae.

Table 2.
Comparison of RAPIDEC CARBA NP test with CPE phenotypic test
acm-19-59f2.tif
TOOLS
Similar articles